NewsCBDUS ‘Marijuana’ Entrepreneur Launches CBD Range in UK

US ‘Marijuana’ Entrepreneur Launches CBD Range in UK


AMERICAN cannabis entrepreneur Ralph Morgan decamped to the UK to launch his new CBD wellness company – Collective Hemp Brands.

The co-founder of Organa Brands has teamed with leading UK-based doctor Dani Gordon to launch the new range featuring daily CBD supplements, pet care, and skin and sun care products. 

In a press release Mr Morgan and Dr Gordon said the vision for new Colorado-based business is to engage with consumers on their medical journeys.

Mr Morgan, Chief Executive Officer of Collective Hemp, said he has ‘traded’ the marijuana industry for cannabinoid therapies because ‘I believe the new movement in healthcare is natural remedies’.

He continued: “This is the age of natural remedies and the era of CBD. It is my goal to amass wide scale behaviour change and help consumers reconnect with the cannabis plant, its cannabinoid properties, and a more natural wellness regime.”

Dr Gordon, a partner in the company as well as Collective Hemp’s Chief Medical Officer, is a recognised expert in cannabinoid medicine and CBD wellness. 

She says she is formulating products based on research and ‘botanical medicine and cannabinoid formulations she has used for years’. 

“Patients are no longer completely relying on their general practitioners for wellness advice and want a more holistic approach to chronic health symptoms and stress-related issues that western medicine, drug-based approaches are not solving well,” she explained.

Founded in Denver 2012 Organa Brands has annual sales of $100m and was was recently acquired by SLANG Worldwide. 

Organa Brands is a supplier of vape pens, edibles and other infused products.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you